|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2011-4-19
|
|
pubmed:abstractText |
To assess the safety and efficacy of 48 weeks of re-treatment with peginterferon ?-2a (40 kD) plus ribavirin in previously treated hepatitis C virus (HCV) genotype 1 patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1473-5687
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
375-81
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21502923-Adult,
pubmed-meshheading:21502923-Antiviral Agents,
pubmed-meshheading:21502923-Drug Therapy, Combination,
pubmed-meshheading:21502923-Europe, Eastern,
pubmed-meshheading:21502923-Female,
pubmed-meshheading:21502923-Hepatitis C, Chronic,
pubmed-meshheading:21502923-Humans,
pubmed-meshheading:21502923-Interferon-alpha,
pubmed-meshheading:21502923-Interferons,
pubmed-meshheading:21502923-Liver Cirrhosis,
pubmed-meshheading:21502923-Male,
pubmed-meshheading:21502923-Middle Aged,
pubmed-meshheading:21502923-Polyethylene Glycols,
pubmed-meshheading:21502923-RNA, Viral,
pubmed-meshheading:21502923-Recombinant Proteins,
pubmed-meshheading:21502923-Ribavirin,
pubmed-meshheading:21502923-Treatment Failure,
pubmed-meshheading:21502923-Viral Load
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Efficacy and safety of peginterferon ?-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon and ribavirin: an open-label study in central and Eastern Europe.
|
|
pubmed:affiliation |
Department of Infectious Diseases, Faculty Hospital and Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic. phusa@fnbrno.cz
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
